693 related articles for article (PubMed ID: 21070457)
1. Multicenter, randomized, parallel-group study of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation: satisfaction and patient-reported outcomes.
Carruthers J; Carruthers A; Monheit GD; Davis PG
Dermatol Surg; 2010 Dec; 36 Suppl 4():2135-45. PubMed ID: 21070457
[TBL] [Abstract][Full Text] [Related]
2. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation.
Carruthers A; Carruthers J; Monheit GD; Davis PG; Tardie G
Dermatol Surg; 2010 Dec; 36 Suppl 4():2121-34. PubMed ID: 21134044
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type a for facial rejuvenation: treatment evolution and patient satisfaction.
Sepehr A; Chauhan N; Alexander AJ; Adamson PA
Aesthetic Plast Surg; 2010 Oct; 34(5):583-6. PubMed ID: 20383497
[TBL] [Abstract][Full Text] [Related]
4. Patient Satisfaction and Efficacy of Full-Facial Rejuvenation Using a Combination of Botulinum Toxin Type A and Hyaluronic Acid Filler.
Molina B; David M; Jain R; Amselem M; Ruiz-Rodriguez R; Ma MY; Kerrouche N; Georgantopoulos SP; Radeau T; Boineau D
Dermatol Surg; 2015 Dec; 41 Suppl 1():S325-32. PubMed ID: 26618460
[TBL] [Abstract][Full Text] [Related]
5. Facial rejuvenation after intradermal botulinum toxin: is it really the botulinum toxin or is it the pricks?
Kapoor R; Shome D; Jain V; Dikshit R
Dermatol Surg; 2010 Dec; 36 Suppl 4():2098-105. PubMed ID: 21134041
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid fillers for the male patient.
Monheit GD; Prather CL
Dermatol Ther; 2007; 20(6):394-406. PubMed ID: 18093013
[TBL] [Abstract][Full Text] [Related]
7. Aging well--the role of minimally invasive aesthetic dermatological procedures in women over 65.
Wollina U; Payne CR
J Cosmet Dermatol; 2010 Mar; 9(1):50-8. PubMed ID: 20367673
[TBL] [Abstract][Full Text] [Related]
8. Nonsurgical periocular rejuvenation: advanced cosmetic uses of neuromodulators and fillers.
Pao KY; Mancini R
Curr Opin Ophthalmol; 2014 Sep; 25(5):461-9. PubMed ID: 24926573
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid filler and botulinum Neurotoxin delivered simultaneously in the same syringe for effective and convenient combination aesthetic rejuvenation therapy.
Kenner JR
J Drugs Dermatol; 2010 Sep; 9(9):1135-8. PubMed ID: 20865847
[TBL] [Abstract][Full Text] [Related]
10. [Wrinkle fillers in cosmetic facial procedures].
Jaspers GW; Schepers RH; Pijpe J; Jansma J
Ned Tijdschr Tandheelkd; 2014 May; 121(5):269-74. PubMed ID: 24881255
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of headache relief with cosmetic onabotulinumtoxinA injections.
Goldman ND; Dorton LH; Marcum KK; Gilbert RM; Sandoval LF
J Cosmet Dermatol; 2014 Sep; 13(3):224-31. PubMed ID: 25196690
[TBL] [Abstract][Full Text] [Related]
12. Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin.
Beer KR; Julius H; Dunn M; Wilson F
J Cosmet Dermatol; 2014 Jun; 13(2):143-50. PubMed ID: 24910278
[TBL] [Abstract][Full Text] [Related]
13. Comparison of treatment of melomental fold rhytides with cross-linked hyaluronic acid combined with onabotulinumtoxina and cross-linked hyaluronic acid alone.
Custis T; Beynet D; Carranza D; Greco J; Lask GP; Kim J
Dermatol Surg; 2010 Nov; 36 Suppl 3():1852-8. PubMed ID: 20969662
[TBL] [Abstract][Full Text] [Related]
14. Optimizing facial rejuvenation outcomes by combining poly-L-lactic acid, hyaluronic acid, calcium hydroxylapatite, and neurotoxins: two case studies.
Lorenc ZP; Daro-Kaftan E
J Drugs Dermatol; 2014 Feb; 13(2):191-5. PubMed ID: 24509971
[TBL] [Abstract][Full Text] [Related]
15. Volumizing with a 20-mg/mL smooth, highly cohesive, viscous hyaluronic acid filler and its role in facial rejuvenation therapy.
Carruthers J; Carruthers A; Tezel A; Kraemer J; Craik L
Dermatol Surg; 2010 Nov; 36 Suppl 3():1886-92. PubMed ID: 20969666
[TBL] [Abstract][Full Text] [Related]
16. European evaluation of a new hyaluronic acid filler incorporating lidocaine.
Wahl G
J Cosmet Dermatol; 2008 Dec; 7(4):298-303. PubMed ID: 19146607
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive botulinum toxin type A: fillers and light-based therapies.
Carruthers J; Carruthers A
Int Ophthalmol Clin; 2005; 45(3):143-51. PubMed ID: 15970773
[No Abstract] [Full Text] [Related]
18. OnabotulinumtoxinA and Hyaluronic Acid in Facial Wrinkles and Folds: A Prospective, Open-Label Comparison.
Cohen JL; Swift A; Solish N; Fagien S; Glaser DA
Aesthet Surg J; 2019 Jan; 39(2):187-200. PubMed ID: 29762642
[TBL] [Abstract][Full Text] [Related]
19. Juvéderm: a hyaluronic acid dermal filler.
Monheit GD; Prather CL
J Drugs Dermatol; 2007 Nov; 6(11):1091-5. PubMed ID: 18038495
[TBL] [Abstract][Full Text] [Related]
20. Studying the satisfaction of patients on the outcome of an aesthetic dermatological filler treatment.
de Arruda LH; Rocha FT; Rocha A
J Cosmet Dermatol; 2008 Dec; 7(4):246-50. PubMed ID: 19146599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
